HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Smith, A. L. Search for Related Content PubMed PubMed Citation Articles by Smith, A. L.

Genetic Resistance to Lethal Flavivirus Encephalitis: Effect of Host Age and Immune Status and Route of Inoculation on Production of Interfering Banzi Virus in Vivo^*

Phenotypic expression of resistance to Banzi virus infection by C3H/RV mice develops at about 4 weeks of age and occurs when the virus is given at a peripheral inoculation site. In contrast, young or adult congenic C3H/He mice die with an encephalitic illness regardless of the route of inoculation. Data are presented here which suggest that interfering virus (I.V.) production by mice genetically resistant to lethal flavivirus encephalitis may contribute to their survival. The level of I.V. in the brains of weanling C3H/RV mice was lower and I.V. was detected for a shorter period of time than in brains of adult resistant mice. After intracerebral inoculation of virus, to which the C3H/RV mice succumb, I.V. was not detected in the brain at any time after infection. Interfering virus production appeared to originate in cells of the lymphoreticular system with subsequent amplification in the central nervous system. Cyclophosphamide, an immunosuppressive drug which compromises resistance of C3H/RV mice to lethal Banzi virus infection, enhanced production of I.V. in the brains of resistant mice and stimulated I.V. production in the brains of susceptible C3H/He mice. It is hypothesized that I.V. is produced, initially, by a lymphoid cell type which is cyclophosphamide-resistant.

Accepted for publication February 28, 1981.

^* This research was supported by grant number 5 RO1 AI 14712 from the National Institutes of Health. A portion of the work reported was presented at the 1980 Annual Meeting of The American Society of Tropical Medicine and Hygiene.